论文部分内容阅读
目的:探讨卡介苗多糖核酸治疗小儿支气管哮喘的有效性和安全性。方法:分析2013年1月到2013年12月在我院使用卡介苗多糖核酸治疗的60名患有小儿支气管哮喘的儿童病例,并对患者进行6个月随访。结果:患者治愈恢复情况良好,血内免疫球蛋白数增高,治愈后发作次数减少且易于控制。结论:卡介苗多糖核酸治疗小儿支气管哮喘能增强小儿免疫能力,减少发作次数此方法安全有效。
Objective: To investigate the effectiveness and safety of BCG polysaccharide nucleic acid in the treatment of children with bronchial asthma. Methods: Sixty children with pediatric bronchial asthma treated with BCG-PSN in our hospital from January 2013 to December 2013 were analyzed and followed up for 6 months. Results: The patients recovered well, the number of blood immunoglobulin increased, and the number of seizures decreased after cure and was easy to control. Conclusion: BCG polysaccharide nucleic acid treatment of children with bronchial asthma can enhance children’s immune capacity, reduce the number of attacks this method is safe and effective.